The MEF2A and MEF2D function as scaffold proteins that interact with HDAC1 or p300 in SOD3 expression in THP-1 cells

References

• Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA. 1982;79(24):7634–7638.
   PubMed Web of Science ®Google Scholar
• Faraci FM, Didion SP. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol. 2004;24(8):1367–1373.
   PubMed Web of Science ®Google Scholar
• Teoh-Fitzgerald ML, Fitzgerald MP, Jensen TJ, et al. Genetic and epigenetic inactivation of extracellular superoxide dismutase promotes an invasive phenotype in human lung cancer by disrupting ECM homeostasis. Mol Cancer Res. 2012;10(1):40–51.
   PubMed Web of Science ®Google Scholar
• Vachier I, Chanez P, Le Doucen C, et al. Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. Eur Respir J. 1994;7(9):1585–1592.
   PubMed Web of Science ®Google Scholar
• Wright E Jr, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int J Clin Pract. 2006;60(3):308–314.
   PubMed Web of Science ®Google Scholar
• Zelko IN, Stepp MW, Vorst AL, et al. Histone acetylation regulates the cell-specific and interferon-γ-inducible expression of extracellular superoxide dismutase in human pulmonary arteries. Am J Respir Cell Mol Biol. 2011;45(5):953–961.
   PubMed Web of Science ®Google Scholar
• O’Leary BR, Fath MA, Bellizzi AM, et al. Loss of SOD3 (EcSOD) expression promotes an aggressive phenotype in human pancreatic ductal adenocarcinoma. Clin Cancer Res. 2015;21(7):1741–1751.
   PubMed Web of Science ®Google Scholar
• Kamiya T, Machiura M, Makino J, et al. Epigenetic regulation of extracellular-superoxide dismutase in human monocytes. Free Radic Biol Med. 2013;61:197–205.
   PubMed Web of Science ®Google Scholar
• Zhao S, Venkatasubbarao K, Li S, et al. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Cancer Res. 2003;63(10):2624–2630.
   PubMed Web of Science ®Google Scholar
• Yuan H, Reddy MA, Sun G, et al. Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells. Am J Physiol Renal Physiol. 2013;304(5):F601–F613.
   PubMed Web of Science ®Google Scholar
• Aude-Garcia C, Collin-Faure V, Bausinger H, et al. Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression. Biochem J. 2010;430(2):237–244.
   PubMedGoogle Scholar
• Youn HD, Liu JO. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity. 2000;13(1):85–94.
   PubMed Web of Science ®Google Scholar
• Youn HD, Chatila TA, Liu JO. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 2000;19(16):4323–4331.
   PubMed Web of Science ®Google Scholar
• Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Development. 2007;134(23): 4131–4140.
   PubMed Web of Science ®Google Scholar
• Ohashi A, Yasuda H, Kamiya T, et al. CAPE increases the expression of SOD3 through epigenetics in human retinal endothelial cells. J Clin Biochem Nutr. 2017;61(1):6–13.
   PubMed Web of Science ®Google Scholar
• Yasuda H, Ohashi A, Nishida S, et al. Exendin-4 induces extracellular-superoxide dismutase through histone H3 acetylation in human retinal endothelial cells. J Clin Biochem Nutr. 2016;59(3):174–181.
   PubMed Web of Science ®Google Scholar
• Kamiya T, Makino J, Hara H, et al. Extracellular-superoxide dismutase expression during monocytic differentiation of U937 cells. J Cell Biochem. 2011;112(1):244–255.
   PubMed Web of Science ®Google Scholar
• Makino J, Kamiya T, Hara H, et al. TPA induces the expression of EC-SOD in human monocytic THP-1 cells: involvement of PKC, MEK/ERK and NOX-derived ROS. Free Radic Res. 2012;46(5):637–644.
   PubMed Web of Science ®Google Scholar
• Ornatsky OI, Cox DM, Tangirala P, et al. Post-translational control of the MEF2A transcriptional regulatory protein. Nucleic Acids Res. 1999;27(13):2646–2654.
   PubMed Web of Science ®Google Scholar
• McGee SL, Hargreaves M. Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms. Clin Exp Pharmacol Physiol. 2006;33(4):395–399.
   PubMed Web of Science ®Google Scholar
• Teoh-Fitzgerald ML, Fitzgerald MP, Zhong W, et al. Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis. Oncogene. 2014;33(3): 358–368.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997;82(2):291–295.
   PubMed Web of Science ®Google Scholar
• Adachi T, Marklund SL. Interactions between human extracellular superoxide dismutase C and sulfated polysaccharides. J Biol Chem. 1989;264(15):8537–8541.
   PubMed Web of Science ®Google Scholar
• Adachi T, Inoue M, Hara H, et al. Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol. 2004;181(3):413–417.
   PubMed Web of Science ®Google Scholar
• Fujita H, Fujishima H, Chida S, et al. Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol. 2009;20(6):1303–1313.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liao M, Dufau ML. Phosphatidylinositol 3- kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene. Mol Cell Biol. 2006;26(18):6748–6761.
   PubMed Web of Science ®Google Scholar
• Perry RL, Yang C, Soora N, et al. Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1α represses MEF2-dependent gene expression. Mol Cell Biol. 2009;29(12):3355–3366.
   PubMed Web of Science ®Google Scholar
• Andrés V, Cervera M, Mahdavi V. Determination of the consensus binding site for MEF2 expressed in muscle and brain reveals tissue-specific sequence constraints. J Biol Chem. 1995;270(40):23246–23249.
   PubMed Web of Science ®Google Scholar
• Fickett JW. Quantitative discrimination of MEF2 sites. Mol Cell Biol. 1996;16(1):437–441.
   PubMed Web of Science ®Google Scholar
• Gossett LA, Kelvin DJ, Sternberg EA, et al. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol Cell Biol. 1989;9(11):5022–5033.
   PubMed Web of Science ®Google Scholar
• Molkentin JD, Olson EN. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci USA. 1996;93(18):9366–9373.
   PubMed Web of Science ®Google Scholar
• Pollock R, Treisman R. Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev. 1991;5(12A):2327–2341.
   PubMed Web of Science ®Google Scholar
• Yu YT, Breitbart RE, Smoot LB, et al. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 1992;6(9):1783–1798.
   PubMed Web of Science ®Google Scholar
• Grégoire S, Xiao L, Nie J, et al. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol. 2007;27(4):1280–1295.
   PubMed Web of Science ®Google Scholar
• Lemercier C, Verdel A, Galloo B, et al. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J Biol Chem. 2000;275(20): 15594–15599.
   PubMed Web of Science ®Google Scholar
• Lu J, McKinsey TA, Nicol RL, et al. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc Natl Acad Sci USA. 2000;97(8):4070–4075.
   PubMed Web of Science ®Google Scholar
• Dressel U, Bailey PJ, Wang SC, et al. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J Biol Chem. 2001;276(20):17007–17013.
   PubMed Web of Science ®Google Scholar
• Kao HY, Verdel A, Tsai CC, et al. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J Biol Chem. 2001;276(50):47496–47507.
   PubMed Web of Science ®Google Scholar
• Zhang CL, McKinsey TA, Chang S, et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell. 2002;110(4):479–488.
   PubMed Web of Science ®Google Scholar
• De Luca A, Severino A, De Paolis P, et al. p300/cAMP-response-element-binding-protein (’CREB’)-binding protein (CBP)-modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor). Biochem J. 2003;369(3):477–484.
   PubMedGoogle Scholar
• Ma K, Chan JK, Zhu G, et al. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol Cell Biol. 2005;25(9):3575–3582.
   PubMed Web of Science ®Google Scholar
• Marklund SL. Expression of extracellular superoxide dismutase by human cell lines. Biochem J. 1990; 266(1):213–219.
   PubMed Web of Science ®Google Scholar
• Morisawa S, Yasuda H, Kamiya T, et al. Tumor necrosis factor-α decreases EC-SOD expression through DNA methylation. J Clin Biochem Nutr. 2017;60(3):169–175.
   PubMed Web of Science ®Google Scholar